GWP
ESPR icon

Gen-Wealth Partners’s Esperion Therapeutics ESPR Stock Holding History

Gen-Wealth Partners’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356 Hold
130
– – ﹤0.01% 704
2025
Q4 		$481 Hold
130
– – ﹤0.01% 662
2025
Q3 		$345 Hold
130
– – ﹤0.01% 664
2025
Q2 		$128 Hold
130
– – ﹤0.01% 635
2025
Q1 		$187 Hold
130
– – ﹤0.01% 607
2024
Q4 		$286 Hold
130
– – ﹤0.01% 634
2024
Q3 		$277 Hold
130
– – ﹤0.01% 646
2024
Q2 		$289 Hold
130
– – ﹤0.01% 629
2024
Q1 		$348 Buy
+130
New +$316 ﹤0.01% 611

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return